港股出口型股全線下跌 海外疫情再現惡化跡象
格隆匯6月22日丨港股出口型股全線下跌,其中,敏華控股和耐世特跌超4%,新秀麗跌超3%,敏實集團、創科實業跌近3%,申洲國際跌超2%。海外疫情近期有惡化的跡象,從疫情數據來看,6月21日全天,全球新增新冠肺炎確診病例達到驚人的16.06萬例,截止6月22日14:00左右,全球累計確診病例895.24萬例,累計死亡人數46.83萬例。其中,美國新增新冠肺炎確診病例飆升,整體明顯反彈,20日新增超3萬例。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.